Newer Clinical Strategies for Combining Interferon and Cytotoxic Agents Against Solid Tumours and Hematological Malignancies

Canadian Journal of Infectious Diseases
doi 10.1155/1994/474259
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Positive and Negative Regulation of Apoptotic Pathways by Cytotoxic Agents in Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

T Lymphocytes Against Solid Malignancies: Winning Ways to Defeat Tumours

Cell Stress
2018English

Histone Deacetylase Inhibitors: Clinical Implications for Hematological Malignancies

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2010English

Hematological Malignancies: Epidemiological, Clinical, Biological, Therapeutic and Evolutionary Aspects

American Journal of Laboratory Medicine
2019English

Discovery and Application of Immune Biomarkers for Hematological Malignancies

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2017English

Clinical Strategies and Animal Models for Developing Senolytic Agents

Experimental Gerontology
AgingGeneticsCell BiologyMolecular BiologyBiochemistryEndocrinology
2015English

A Quantitative in Silico Platform for Simulating Cytotoxic and Nanoparticle Drug Delivery to Solid Tumours

Interface Focus
BiochemistryBiophysicsBiomaterialsBioengineeringBiotechnologyBiomedical Engineering
2019English

Advances in Immunotherapy for Hematological Malignancies

Journal of Nihon University Medical Association
2016English

Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma

OncoImmunology
OncologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy